Evaluation of ex vivo drug combination optimization platform in recurrent high grade astrocytic glioma: An interventional, non-randomized, open-label trial protocol.
Saved in:
| Title: | Evaluation of ex vivo drug combination optimization platform in recurrent high grade astrocytic glioma: An interventional, non-randomized, open-label trial protocol. |
|---|---|
| Authors: | Toh TB; The N.1 Institute for Health (N.1), National University of Singapore, Singapore, Singapore.; The Institute for Digital Medicine (WisDM), National University of Singapore, Singapore, Singapore., Thng DKH; The N.1 Institute for Health (N.1), National University of Singapore, Singapore, Singapore.; Cancer Science Institute of Singapore (CSI), National University of Singapore, Singapore, Singapore., Bolem N; Division of Neurosurgery, Department of Surgery, National University Hospital, Singapore, Singapore., Vellayappan BA; Department of Radiation Oncology, National University Cancer Institute, Singapore, Singapore., Tan BWQ; Cancer Science Institute of Singapore (CSI), National University of Singapore, Singapore, Singapore., Shen Y; The N.1 Institute for Health (N.1), National University of Singapore, Singapore, Singapore.; Cancer Science Institute of Singapore (CSI), National University of Singapore, Singapore, Singapore., Soon SY; Department of Haematology-Oncology, National University Hospital, Singapore, Singapore., Ang YLE; Department of Haematology-Oncology, National University Hospital, Singapore, Singapore., Dinesh N; Division of Neurosurgery, Department of Surgery, National University Hospital, Singapore, Singapore., Teo K; Division of Neurosurgery, Department of Surgery, National University Hospital, Singapore, Singapore., Nga VDW; Division of Neurosurgery, Department of Surgery, National University Hospital, Singapore, Singapore., Low SW; Division of Neurological Surgery, Ng Teng Fong General Hospital, Singapore, Singapore., Khong PL; Department of Diagnostic Imaging, National University Hospital, Singapore, Singapore.; Clinical Imaging Research Centre (CIRC), National University of Singapore, Singapore, Singapore., Chow EK; The N.1 Institute for Health (N.1), National University of Singapore, Singapore, Singapore.; The Institute for Digital Medicine (WisDM), National University of Singapore, Singapore, Singapore.; Cancer Science Institute of Singapore (CSI), National University of Singapore, Singapore, Singapore., Ho D; The N.1 Institute for Health (N.1), National University of Singapore, Singapore, Singapore.; The Institute for Digital Medicine (WisDM), National University of Singapore, Singapore, Singapore., Yeo TT; Division of Neurosurgery, Department of Surgery, National University Hospital, Singapore, Singapore., Wong ALA; Cancer Science Institute of Singapore (CSI), National University of Singapore, Singapore, Singapore.; Department of Haematology-Oncology, National University Hospital, Singapore, Singapore. |
| Source: | PloS one [PLoS One] 2024 Jul 26; Vol. 19 (7), pp. e0307818. Date of Electronic Publication: 2024 Jul 26 (Print Publication: 2024). |
| Publication Type: | Journal Article; Clinical Trial Protocol |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39058662 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Evaluation of ex vivo drug combination optimization platform in recurrent high grade astrocytic glioma: An interventional, non-randomized, open-label trial protocol. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Toh+TB%22">Toh TB</searchLink>; The N.1 Institute for Health (N.1), National University of Singapore, Singapore, Singapore.; The Institute for Digital Medicine (WisDM), National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Thng+DKH%22">Thng DKH</searchLink>; The N.1 Institute for Health (N.1), National University of Singapore, Singapore, Singapore.; Cancer Science Institute of Singapore (CSI), National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Bolem+N%22">Bolem N</searchLink>; Division of Neurosurgery, Department of Surgery, National University Hospital, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Vellayappan+BA%22">Vellayappan BA</searchLink>; Department of Radiation Oncology, National University Cancer Institute, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Tan+BWQ%22">Tan BWQ</searchLink>; Cancer Science Institute of Singapore (CSI), National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Shen+Y%22">Shen Y</searchLink>; The N.1 Institute for Health (N.1), National University of Singapore, Singapore, Singapore.; Cancer Science Institute of Singapore (CSI), National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Soon+SY%22">Soon SY</searchLink>; Department of Haematology-Oncology, National University Hospital, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Ang+YLE%22">Ang YLE</searchLink>; Department of Haematology-Oncology, National University Hospital, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Dinesh+N%22">Dinesh N</searchLink>; Division of Neurosurgery, Department of Surgery, National University Hospital, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Teo+K%22">Teo K</searchLink>; Division of Neurosurgery, Department of Surgery, National University Hospital, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Nga+VDW%22">Nga VDW</searchLink>; Division of Neurosurgery, Department of Surgery, National University Hospital, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Low+SW%22">Low SW</searchLink>; Division of Neurological Surgery, Ng Teng Fong General Hospital, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Khong+PL%22">Khong PL</searchLink>; Department of Diagnostic Imaging, National University Hospital, Singapore, Singapore.; Clinical Imaging Research Centre (CIRC), National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Chow+EK%22">Chow EK</searchLink>; The N.1 Institute for Health (N.1), National University of Singapore, Singapore, Singapore.; The Institute for Digital Medicine (WisDM), National University of Singapore, Singapore, Singapore.; Cancer Science Institute of Singapore (CSI), National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Ho+D%22">Ho D</searchLink>; The N.1 Institute for Health (N.1), National University of Singapore, Singapore, Singapore.; The Institute for Digital Medicine (WisDM), National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Yeo+TT%22">Yeo TT</searchLink>; Division of Neurosurgery, Department of Surgery, National University Hospital, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Wong+ALA%22">Wong ALA</searchLink>; Cancer Science Institute of Singapore (CSI), National University of Singapore, Singapore, Singapore.; Department of Haematology-Oncology, National University Hospital, Singapore, Singapore. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2024 Jul 26; Vol. 19 (7), pp. e0307818. <i>Date of Electronic Publication: </i>2024 Jul 26 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial Protocol – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39058662 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pone.0307818 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e0307818 Titles: – TitleFull: Evaluation of ex vivo drug combination optimization platform in recurrent high grade astrocytic glioma: An interventional, non-randomized, open-label trial protocol. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Toh TB – PersonEntity: Name: NameFull: Thng DKH – PersonEntity: Name: NameFull: Bolem N – PersonEntity: Name: NameFull: Vellayappan BA – PersonEntity: Name: NameFull: Tan BWQ – PersonEntity: Name: NameFull: Shen Y – PersonEntity: Name: NameFull: Soon SY – PersonEntity: Name: NameFull: Ang YLE – PersonEntity: Name: NameFull: Dinesh N – PersonEntity: Name: NameFull: Teo K – PersonEntity: Name: NameFull: Nga VDW – PersonEntity: Name: NameFull: Low SW – PersonEntity: Name: NameFull: Khong PL – PersonEntity: Name: NameFull: Chow EK – PersonEntity: Name: NameFull: Ho D – PersonEntity: Name: NameFull: Yeo TT – PersonEntity: Name: NameFull: Wong ALA IsPartOfRelationships: – BibEntity: Dates: – D: 26 M: 07 Text: 2024 Jul 26 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1932-6203 Numbering: – Type: volume Value: 19 – Type: issue Value: 7 Titles: – TitleFull: PloS one Type: main |
| ResultId | 1 |
